Clinical Outcomes after Upfront Surgery in Clinical Stage I-IIA Small Cell Lung Cancer |
Hyeok Sang, Woo
(Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital)
Jae Won, Song (Center for Lung Cancer, Research Institute and Hospital, National Cancer Center) Samina, Park (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) In Kyu, Park (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) Chang Hyun, Kang (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) Young Tae, Kim (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) |
1 | Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2018. Bethesda (MD): National Cancer Institute; 2021. |
2 | Breitling LP, Rinke A, Gress TM. Recent survival trends in highgrade neuroendocrine neoplasms and lung cancer. Neuroendocrinology 2020;110:225-33. https://doi.org/10.1159/000500883 DOI |
3 | Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-77. https://doi.org/10.1097/JTO.0b013e31815bdc0d DOI |
4 | Amin MB, Edge SB, Greene FL, et al. Lung. In: Amin MB, Edge SB, Greene FL, et al., editors. AJCC cancer staging manual. 8th ed. Cham: Springer; 2017. p. 431-55. |
5 | Nicholson AG, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016;11:300-11. https://doi.org/10.1016/j.jtho.2015.10.008 DOI |
6 | Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Canc Netw 2021;19:254-66. https://doi.org/10.6004/jnccn.2021.0013 DOI |
7 | Combs SE, Hancock JG, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Bolstering the case for lobectomy in stages I, II, and IIIA smallcell lung cancer using the National Cancer Data Base. J Thorac Oncol 2015;10:316-23. https://doi.org/10.1097/JTO.0000000000000402 DOI |
8 | Takei H, Kondo H, Miyaoka E, et al. Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004. J Thorac Oncol 2014;9:1140-5. https://doi.org/10.1097/JTO.0000000000000226 DOI |
9 | Takenaka T, Takenoyama M, Inamasu E, et al. Role of surgical resection for patients with limited disease-small cell lung cancer. Lung Cancer 2015;88:52-6. https://doi.org/10.1016/j.lungcan.2015.01.010 DOI |
10 | Yang CJ, Chan DY, Shah SA, et al. Long-term survival after surgery compared with concurrent chemoradiation for node-negative small cell lung cancer. Ann Surg 2018;268:1105-12. https://doi.org/10.1097/SLA.0000000000002287 DOI |
11 | Shewale JB, Corsini EM, Correa AM, et al. Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol 2020;122:495-505. https://doi.org/10.1002/jso.25966 DOI |
12 | Thomas DC, Arnold BN, Rosen JE, et al. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery. Lung Cancer 2017;103:75-81. https://doi.org/10.1016/j.lungcan.2016.11.016 DOI |
13 | Leuzzi G, Lococo F, Alessandrini G, et al. Prognostic impact of node-spreading pattern in surgically treated small-cell lung cancer: a multicentric analysis. Lung 2017;195:107-14. https://doi.org/10.1007/s00408-016-9954-4 DOI |
14 | Haruki T, Takagi Y, Kubouchi Y, et al. Comparison between robot-assisted thoracoscopic surgery and video-assisted thoracoscopic surgery for mediastinal and hilar lymph node dissection in lung cancer surgery. Interact Cardiovasc Thorac Surg 2021;33:409-17. https://doi.org/10.1093/icvts/ivab112 DOI |
15 | Kneuertz PJ, Cheufou DH, D'Souza DM, et al. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg 2019;158:1457-66. https://doi.org/10.1016/j.jtcvs.2019.06.113 DOI |
16 | Casiraghi M, Sedda G, Del Signore E, et al. Surgery for small cell lung cancer: when and how. Lung Cancer 2021;152:71-7. https://doi.org/10.1016/j.lungcan.2020.12.006 DOI |
17 | Yang H, Mei T. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Eur J Cardiothorac Surg 2021;60:1212-20. https://doi.org/10.1093/ejcts/ezab287 DOI |
18 | Leong TL, Loveland PM, Gorelik A, Irving L, Steinfort DP. Preoperative staging by EBUS in cN0/N1 lung cancer: systematic review and meta-analysis. J Bronchology Interv Pulmonol 2019;26:155-65. https://doi.org/10.1097/LBR.0000000000000545 DOI |
19 | Bott MJ, Patel AP, Crabtree TD, et al. Pathologic upstaging in patients undergoing resection for stage I non-small cell lung cancer: are there modifiable predictors? Ann Thorac Surg 2015;100:2048-53. https://doi.org/10.1016/j.athoracsur.2015.05.100 DOI |
20 | Lad T, Piantadosi S, Thomas P, Payne D, Ruckdeschel J, Giaccone G. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994;106(6 Suppl):320S323S. https://doi.org/10.1378/chest.106.6_supplement.320s DOI |
21 | Badzio A, Kurowski K, Karnicka-Mlodkowska H, Jassem J. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg 2004;26:183-8. https://doi.org/10.1016/j.ejcts.2004.04.012 DOI |
22 | Zhou N, Bott M, Park BJ, et al. Predictors of survival following surgical resection of limited-stage small cell lung cancer. J Thorac Cardiovasc Surg 2021;161:760-71. https://doi.org/10.1016/j.jtcvs.2020.10.148 DOI |
23 | Patel S, Macdonald OK, Suntharalingam M. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer 2009;115:842-50. https://doi.org/10.1002/cncr.24105 DOI |
24 | Eze C, Roengvoraphoj O, Niyazi M, et al. Treatment response and prophylactic cranial irradiation are prognostic factors in a real-life limited-disease small-cell lung cancer patient cohort comprehensively staged with cranial magnetic resonance imaging. Clin Lung Cancer 2017;18:e243-9. https://doi.org/10.1016/j.cllc.2016.11.005 DOI |
![]() |